The Microbiome in PDAC—Vantage Point for Future Therapies?

SIMPLE SUMMARY: Pancreatic cancer is a highly lethal cancer and less than 10% of patients survive the 5-year mark. The molecular and biological underpinnings leading to this dismal prognosis are well-described, however, translation of these findings with subsequent improvement of the poor prognosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfisterer, Nina, Lingens, Catharina, Heuer, Cathleen, Dang, Linh, Neesse, Albrecht, Ammer-Herrmenau, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739548/
https://www.ncbi.nlm.nih.gov/pubmed/36497456
http://dx.doi.org/10.3390/cancers14235974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739548/
https://www.ncbi.nlm.nih.gov/pubmed/36497456
http://dx.doi.org/10.3390/cancers14235974

Ejemplares similares